Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0704-2017

Drug recall · May 17, 2017

Mozobil recall

Why: Labeling: Incorrect or Missing Package Insert

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Lots / codes

Lot #: 5RZ001C, 5RZ001D; Exp. 04/18

Quantity
2133 vials
Company
Sanofi-Aventis U.S. LLC, Bridgewater, NJ
Distribution
Nattionwide
Initiated
September 1, 2016 · Voluntary: Firm initiated
Classified
May 11, 2017
Reported
May 17, 2017
Ended
February 15, 2018
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Plerixafor

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.